The first randomised trial comparing efficacy of a highly selective RET-kinase inhibitor with multikinase inhibitors (MKIs) in advanced medullary thyroid cancer (MTC) has delivered...
ARTICLE | Discovery & TranslationBioCentury’s roundup of translational innovations By Danielle Golovin, Biopharma Analyst
August 19, 2023 12:52 AM UTC
A team including Nathanael Gray from...
ARTICLE | Management TracksPlus: Jones hired as CCO at NewAmsterdam, and updates from Foresight, Kronos, Antheia and more By Richard Guy, Biopharma Analyst, and Gunjan...
ARTICLE | Politics, Policy & LawAug. 9 order on outbound investment names AI as a sensitive technology for deal scrutiny, but a concurrent rulemaking notice...
ProRelix Research is the best clinical research organization (CRO) with global service capability supporting Phase 1, 2, 3, & 4 clinical trials for Pharma,...
SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of...
--Must See--
Biotecnika Times Newsletter 11.08.2023 Freshers Job Merck, Project Intern, TIGS Hiring, Workshop Registrations Open + Much More
Freshers Job at Merck – MSc...